Literature DB >> 429800

Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.

W W Crawford, I P Crawford, R B Stoughton, R C Cornell.   

Abstract

Corynebacterium acnes strains cross-resistant to clindamycin and erythromycin were observed following long-term selection or mutagenic treatment in the laboratory. Similar strains were found among clinical isolates from patients using clindamycin or erythromycin topically in the treatment of acne vulgaris. Clindamycin resistance was never observed in the absence of resistance to macrolides or other lincosaminides. It is suggested that this resistance may result from an alteration of the 50S ribosomal subunit.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 429800     DOI： 10.1111/1523-1747.ep12676385

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  9 in total

1.  Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Authors:  J I Ross; E A Eady; J H Cove; C E Jones; A H Ratyal; Y W Miller; S Vyakrnam; W J Cunliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 2.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.

Authors:  E A Eady; C E Jones; J L Tipper; J H Cove; W J Cunliffe; A M Layton
Journal:  BMJ       Date:  1993-02-27

4.  Acne vulgaris: pathogenesis and treatment.

Authors:  W J Cunliffe
Journal:  Br Med J       Date:  1980-06-14

5.  Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives.

Authors:  James J Leyden; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-02

6.  A small peptide with therapeutic potential for inflammatory acne vulgaris.

Authors:  Zhiye Zhang; Lixian Mu; Jing Tang; Zilei Duan; Fengyu Wang; Lin Wei; Mingqiang Rong; Ren Lai
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 7.  Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.

Authors:  Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Maciej Żaczek; Ryszard Międzybrodzki; Sławomir Letkiewicz; Marzanna Łusiak-Szelchowska; Andrzej Górski
Journal:  Front Microbiol       Date:  2017-02-08       Impact factor: 5.640

8.  Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study.

Authors:  Nanxue Zhang; Ruoyue Yuan; Kevin Z Xin; Zhong Lu; Ying Ma
Journal:  Dermatol Ther (Heidelb)       Date:  2019-09-19

9.  Is there an association between long-term antibiotics for acne and subsequent infection sequelae and antimicrobial resistance? A systematic review.

Authors:  Ketaki Bhate; Liang-Yu Lin; John S Barbieri; Clémence Leyrat; Susan Hopkins; Richard Stabler; Laura Shallcross; Liam Smeeth; Nick Francis; Rohini Mathur; Sinéad M Langan; Sarah-Jo Sinnott
Journal:  BJGP Open       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.